Table 2.
Tracer Biodistribution in Human Subjects 1 Hour and 2 Hours after FGln Injection
Note.—Data are averages ± standard deviations.
*Tracer uptake in humerus was considered representative of compact bone and/or osteogenic cell tracer avidity, and tracer uptake in the spine was considered representative of tracer uptake in bone red marrow (see Results). FGln radiation dosimetry is favorable (14).